BR0012429A - Fórmulações para il-11 - Google Patents

Fórmulações para il-11

Info

Publication number
BR0012429A
BR0012429A BR0012429-0A BR0012429A BR0012429A BR 0012429 A BR0012429 A BR 0012429A BR 0012429 A BR0012429 A BR 0012429A BR 0012429 A BR0012429 A BR 0012429A
Authority
BR
Brazil
Prior art keywords
formulations
preparations
administration
obtaining
methods
Prior art date
Application number
BR0012429-0A
Other languages
English (en)
Inventor
Nicholas W Warne
Rebecca L Ingram
Shannon Macmillan
Original Assignee
Genetics Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Inst filed Critical Genetics Inst
Publication of BR0012429A publication Critical patent/BR0012429A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2073—IL-11
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"FORMULAçõES PARA IL-11". A presente invenção fornece composições e métodos novos para obtenção de preparações de IL-11 e formulações de IL-11 adequadas para armazenamento e administração.
BR0012429-0A 1999-07-15 2000-07-14 Fórmulações para il-11 BR0012429A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35439099A 1999-07-15 1999-07-15
PCT/US2000/019347 WO2001005355A2 (en) 1999-07-15 2000-07-14 Formulations for il-11

Publications (1)

Publication Number Publication Date
BR0012429A true BR0012429A (pt) 2002-09-17

Family

ID=23393125

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0012429-0A BR0012429A (pt) 1999-07-15 2000-07-14 Fórmulações para il-11

Country Status (13)

Country Link
US (2) US7033992B2 (pt)
EP (1) EP1368486A4 (pt)
JP (1) JP2003522735A (pt)
AU (1) AU6102600A (pt)
BR (1) BR0012429A (pt)
CA (1) CA2379354A1 (pt)
HU (1) HUP0301349A3 (pt)
IL (2) IL147599A0 (pt)
MX (1) MXPA02000525A (pt)
NO (1) NO20020185L (pt)
NZ (1) NZ516664A (pt)
PL (1) PL360914A1 (pt)
WO (1) WO2001005355A2 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6540993B1 (en) 1995-06-27 2003-04-01 Wyeth Method of treating inflammatory bowel disease using a topical formulation of IL-11
US7790856B2 (en) 1998-04-07 2010-09-07 Janssen Alzheimer Immunotherapy Humanized antibodies that recognize beta amyloid peptide
TWI239847B (en) 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
US20080050367A1 (en) 1998-04-07 2008-02-28 Guriq Basi Humanized antibodies that recognize beta amyloid peptide
US7964192B1 (en) 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
HUP0301349A3 (en) * 1999-07-15 2005-12-28 Genetics Inst Llc Cambridge Formulations for il-11
US7700751B2 (en) 2000-12-06 2010-04-20 Janssen Alzheimer Immunotherapy Humanized antibodies that recognize β-amyloid peptide
MY139983A (en) 2002-03-12 2009-11-30 Janssen Alzheimer Immunotherap Humanized antibodies that recognize beta amyloid peptide
US6982080B2 (en) * 2002-03-15 2006-01-03 Wyeth Hydroxyethyl starch—containing polypeptide compositions
PE20050627A1 (es) 2003-05-30 2005-08-10 Wyeth Corp Anticuerpos humanizados que reconocen el peptido beta amiloideo
JP2006137678A (ja) * 2004-11-10 2006-06-01 Shionogi & Co Ltd インターロイキン−２組成物
AR052051A1 (es) 2004-12-15 2007-02-28 Neuralab Ltd Anticuerpos ab humanizados usados en mejorar la cognicion
GT200600031A (es) 2005-01-28 2006-08-29 Formulacion anticuerpo anti a beta
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
TW200806317A (en) * 2006-03-20 2008-02-01 Wyeth Corp Methods for reducing protein aggregation
US8784810B2 (en) 2006-04-18 2014-07-22 Janssen Alzheimer Immunotherapy Treatment of amyloidogenic diseases
US20080069796A1 (en) * 2006-07-31 2008-03-20 Kim Jong-Mook Low Dose Treatment with an Interleukin-11 Analog
US8003097B2 (en) 2007-04-18 2011-08-23 Janssen Alzheimer Immunotherapy Treatment of cerebral amyloid angiopathy
AU2008245821B2 (en) * 2007-04-26 2013-07-04 Bayer Healthcare Llc Stabilization of liquid solutions of recombinant protein for frozen storage
JP5513380B2 (ja) 2007-06-25 2014-06-04 アムジエン・インコーポレーテツド 肝細胞増殖因子に対する特異的結合剤の組成物
PL2182983T3 (pl) 2007-07-27 2014-10-31 Janssen Alzheimer Immunotherap Leczenie chorób amyloidowych z wykorzystaniem humanizowanych przeciwciał specyficznych względem Abeta
JO3076B1 (ar) 2007-10-17 2017-03-15 Janssen Alzheimer Immunotherap نظم العلاج المناعي المعتمد على حالة apoe
US9067981B1 (en) 2008-10-30 2015-06-30 Janssen Sciences Ireland Uc Hybrid amyloid-beta antibodies
TWI420342B (zh) * 2010-02-01 2013-12-21 Kinpo Elect Inc 多點受控端之遙控系統、方法與應用於該系統之遙控裝置
CN102319206A (zh) * 2011-09-28 2012-01-18 厦门特宝生物工程股份有限公司 一种稳定的重组人白介素-11水溶液及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US585962A (en) * 1897-07-06 Charles f
US5215895A (en) 1989-11-22 1993-06-01 Genetics Institute, Inc. Dna encoding a mammalian cytokine, interleukin-11
US5292773A (en) 1990-02-14 1994-03-08 Hirsch Gerald P Treating aids and HIV infection with methionine
US5371193A (en) * 1990-05-21 1994-12-06 Genetics Institute, Inc. - Legal Affairs Mammalian cytokine, IL-11
EP0546124B2 (en) 1990-08-29 2003-04-23 Genetics Institute, LLC Multidomain hematopoiesis stimulators
US5292646A (en) 1991-02-06 1994-03-08 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
US5270181A (en) 1991-02-06 1993-12-14 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
US6270757B1 (en) 1994-04-21 2001-08-07 Genetics Institute, Inc. Formulations for IL-11
US5580856A (en) * 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof
US5582821A (en) * 1994-07-22 1996-12-10 Genetics Institute, Inc. Methods for treating bleeding disorders
ATE216590T1 (de) * 1995-02-06 2002-05-15 Genetics Inst Arzneimittelformulierungen für il-12
SE9501189D0 (sv) * 1995-03-31 1995-03-31 Pharmacia Ab Protein formulation
US5679339A (en) * 1995-06-27 1997-10-21 Keith; James Method of using IL-11 for treating spondyloarthropies
US5885962A (en) 1996-04-05 1999-03-23 Amgen Inc. Stem cell factor analog compositions and method
JP4382879B2 (ja) * 1996-07-12 2009-12-16 ジェネンテック・インコーポレーテッド ガンマ―ヘレグリン
HUP0301349A3 (en) * 1999-07-15 2005-12-28 Genetics Inst Llc Cambridge Formulations for il-11

Also Published As

Publication number Publication date
US7033992B2 (en) 2006-04-25
NZ516664A (en) 2003-06-30
AU6102600A (en) 2001-02-05
EP1368486A2 (en) 2003-12-10
US20060159656A1 (en) 2006-07-20
EP1368486A4 (en) 2009-04-01
JP2003522735A (ja) 2003-07-29
US20040057927A1 (en) 2004-03-25
CA2379354A1 (en) 2001-01-25
HUP0301349A2 (hu) 2003-08-28
NO20020185D0 (no) 2002-01-14
WO2001005355A2 (en) 2001-01-25
MXPA02000525A (es) 2005-07-01
PL360914A1 (en) 2004-09-20
NO20020185L (no) 2002-03-13
HUP0301349A3 (en) 2005-12-28
IL147599A (en) 2009-09-22
WO2001005355A3 (en) 2003-10-02
IL147599A0 (en) 2002-08-14

Similar Documents

Publication Publication Date Title
BR0012429A (pt) Fórmulações para il-11
ATE244015T1 (de) Formulierungen fuer faktor ix
DE69620877D1 (de) Arzneimittelformulierungen für il-12
AP9901534A0 (en) Pharmaceutical formulations.
PL347671A1 (en) Compounds and compositions for delivering active agents
BR0015567A (pt) Compostos de ácido fenoxicarboxìlico e composições para liberar agentes ativos
PT1093819E (pt) Compostos e composicoes para fornecimento de agentes activos
IL140710A0 (en) Pulmonary delivery of active agents
IL153297A0 (en) Compounds and compositions for delivering active agents
DE69729786D1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
MXPA01008611A (es) Compuestos y composiciones para suministrar agentes activos.
AU2274201A (en) Compounds and compositions for delivering active agents
MY118151A (en) Pharmaceutical formulations containing voriconazole.
BG106586A (en) Pyrazolopyramidines as therapeutic agents
BR9810495A (pt) Composição farmacêutica
DE69524742D1 (de) Interleukin-11 präparat
WO2002015959A3 (en) Compounds and compositions for delivering active agents
DE69928646D1 (de) Derivate des streptogramins, ihre herstellung und sie enthaltende zubereitungen
TR199901209T2 (xx) B�cek �ld�r�c� ve mitisidal kompozisyonlar
PT1017681E (pt) Derivados de hidrazono-benzazuleno composicoes farmaceuticas e intermediarios
EA200000112A1 (ru) Новая композиция
SE9604752D0 (sv) Formulation and use
EP1245562A4 (en) ALCOHOLS 5-THIA- "OMEGA" - (PHENYL SUBSTITUTED) - PROSTAGLANDIN E, PROCESS FOR THE PREPARATION OF SUCH ALCOHOLS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE ALCOHOLS AS ACTIVE INGREDIENT.
ATE208627T1 (de) Orale zusammensetzungen mit niedrigdosierten zytotoxischen proteinen
BR9714382A (pt) 17alfa-diidroequilina para uso como um antioxidante médico

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 13 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.